Cannabinoid immunoassay reagent kits for tamc, hawaii.
Ended Awarded Last action
- Contract number
- W81K0225FA055
- Awardee
-
Siemens Healthcare Diagnostics Inc. UEI GC14SNHB3JN1
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $13,699
Award facts
- Contract value 100% obligated
- $13,698.75 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sleepy Hollow, NY 10591, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency has awarded a delivery order to Siemens Healthcare Diagnostics Inc. valued at $13,698.75 for cannabinoid immunoassay reagent kits intended for use at Tripler Army Medical Center (TAMC) in Hawaii. This is a firm fixed-price contract with an ultimate completion date of May 20, 2025, and represents a child order under a larger indefinite delivery vehicle. The award carries no set-aside designation and reflects a competitive procurement process. Siemens Healthcare Diagnostics, headquartered in Tarrytown, New York, is a subsidiary of Siemens Aktiengesellschaft and specializes in in vitro diagnostic solutions and laboratory services for federal healthcare agencies. The contractor's place of performance is listed as Sleepy Hollow, New York.
This delivery order falls within Siemens Healthcare Diagnostics' established portfolio of federal contracts with the Defense Health Agency and other military medical treatment facilities. The company maintains substantial indefinite delivery contract vehicles with the Defense Logistics Agency and the General Services Administration, as well as multiple blanket purchase agreements with Veterans Integrated Service Networks, enabling efficient procurement of laboratory equipment, supplies, and diagnostic reagents across the federal healthcare system. The cannabinoid immunoassay reagent kits support controlled substance screening capabilities at military medical facilities, consistent with the company's demonstrated expertise in providing specialized diagnostic reagents and testing supplies to the Department of Defense and related healthcare agencies.
Quick answers
Who was awarded contract W81K0225FA055?
W81K0225FA055 was awarded to Siemens Healthcare Diagnostics Inc. by Medical Command (Department of the Army) on May 20, 2025.
How much is contract W81K0225FA055 worth?
The government has obligated $13,699 on W81K0225FA055.
Which agency awarded contract W81K0225FA055?
Medical Command (Department of the Army) awarded W81K0225FA055, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0225FA055 an order under another contract?
Yes. W81K0225FA055 is a delivery order under N6264521D5015, an indefinite delivery contract.
Was contract W81K0225FA055 competed?
The extent of competition for W81K0225FA055 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award